Economic cost of end-stage renal disease in Africa: a systematic review.

ABSTRACT:

Background

Chronic kidney disease (CKD) is a progressive and irreversible condition that contributes substantially to global morbidity and mortality. In Africa, the burden of CKD is compounded by limited healthcare resources, poverty, and the dual challenge of communicable and non-communicable diseases. The economic impact of end-stage renal disease (ESRD) is considerable, yet evidence from the region remains scarce.

Methods

This systematic review, conducted in accordance with PRISMA 2020 guidelines, examined the economic burden of ESRD in Africa. Data were extracted on study characteristics, patient populations, cost components, and financing mechanisms. All reported costs were standardized to 2025 USD.

Results

Eighteen studies, involving 2,634 patients, were include

SUBMITTER: Yakubu AO 

PROVIDER: S-EPMC12502344 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature